Genome-wide meta-analysis of ascertainment and symptom structures of major depression in case-enriched and community cohorts
- PMID: 39324397
- PMCID: PMC11496230
- DOI: 10.1017/S0033291724001880
Genome-wide meta-analysis of ascertainment and symptom structures of major depression in case-enriched and community cohorts
Abstract
Background: Diagnostic criteria for major depressive disorder allow for heterogeneous symptom profiles but genetic analysis of major depressive symptoms has the potential to identify clinical and etiological subtypes. There are several challenges to integrating symptom data from genetically informative cohorts, such as sample size differences between clinical and community cohorts and various patterns of missing data.
Methods: We conducted genome-wide association studies of major depressive symptoms in three cohorts that were enriched for participants with a diagnosis of depression (Psychiatric Genomics Consortium, Australian Genetics of Depression Study, Generation Scotland) and three community cohorts who were not recruited on the basis of diagnosis (Avon Longitudinal Study of Parents and Children, Estonian Biobank, and UK Biobank). We fit a series of confirmatory factor models with factors that accounted for how symptom data was sampled and then compared alternative models with different symptom factors.
Results: The best fitting model had a distinct factor for Appetite/Weight symptoms and an additional measurement factor that accounted for the skip-structure in community cohorts (use of Depression and Anhedonia as gating symptoms).
Conclusion: The results show the importance of assessing the directionality of symptoms (such as hypersomnia versus insomnia) and of accounting for study and measurement design when meta-analyzing genetic association data.
Keywords: Genomic SEM; depressive symptoms; genome-wide association study; major depressive disorder; psychometrics.
Figures






References
-
- Als, T. D., Kurki, M. I., Grove, J., Voloudakis, G., Therrien, K., Tasanko, E., … Børglum, A. D. (2023). Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses. Nature Medicine, 29(7), 1832–1844. doi:10.1038/s41591-023-02352-1 - DOI - PMC - PubMed
-
- American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR (4th ed., text revision). Washington, DC: American Psychiatric Association.
-
- American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders: DSM-5 (5th ed.) Washington, D.C: American Psychiatric Association.
-
- Badini, I., Coleman, J. R. I., Hagenaars, S. P., Hotopf, M., Breen, G., Lewis, C. M., & Fabbri, C. (2022). Depression with atypical neurovegetative symptoms shares genetic predisposition with immuno-metabolic traits and alcohol consumption. Psychological Medicine, 52(4), 726–736. doi:10.1017/S0033291720002342 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- R01 MH081802/MH/NIMH NIH HHS/United States
- R01D0042157-01A, MH081802, Grand Opportunity grants 1RC2 MH089951 and 1RC2 MH089995/NH/NIH HHS/United States
- 217065/Z/19/Z/MRC_/Medical Research Council/United Kingdom
- MC_PC_15018/MRC_/Medical Research Council/United Kingdom
- G9815508/MRC_/Medical Research Council/United Kingdom
- RC2 MH089951/MH/NIMH NIH HHS/United States
- APP1172917, APP1138514 and MRF1200644/National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care North West Coast
- 104036/Z/14/Z; 220857/Z/20/Z)/WT_/Wellcome Trust/United Kingdom
- MC_PC_19009/MRC_/Medical Research Council/United Kingdom
- RC2 MH089995/MH/NIMH NIH HHS/United States
- PSG615/Eesti Teadusagentuur
- 10-000-1002/Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- WT_/Wellcome Trust/United Kingdom
LinkOut - more resources
Full Text Sources